Copyright: ©Author(s) 2026.
World J Psychiatry. Aug 19, 2026; 16(8): 122295
Published online Aug 19, 2026. doi: 10.5498/wjp.122295
Published online Aug 19, 2026. doi: 10.5498/wjp.122295
Table 4 Risk stratification based on number of elevated biomarkers
| Number of elevated biomarkers | n | AD incidence (%) | OR (95%CI) | P value |
| 0 (low risk) | 24 | 12.5 | Reference | - |
| 1 (low-intermediate risk) | 31 | 25.8 | 2.42 (0.68-8.62) | 0.172 |
| 2 (intermediate-high risk) | 32 | 50.0 | 6.84 (2.08-22.52) | 0.002 |
| 3 (high risk) | 38 | 78.9 | 26.32 (7.24-95.68) | < 0.001 |
| P for trend | - | - | - | < 0.001 |
- Citation: Hu X, Tao J, Jiang YL, Liu K. Predictive value of serum inflammatory factors combined with p-tau181 for anxiety and depression in Alzheimer’s disease patients. World J Psychiatry 2026; 16(8): 122295
- URL: https://www.wjgnet.com/2220-3206/full/v16/i8/122295.htm
- DOI: https://dx.doi.org/10.5498/wjp.122295